Osiris Therapeutics is a Maryland-based biotechnology company that researches, develops and commercializes stem cell therapy for tissue regeneration.
Business Model:
Revenue: $150M
Employees: 201-500
Osiris Therapeutics was acquired by
Smith &a; Nephew.
The acquisition happend on 2019-03-12.
Details of the transaction were not public
Address: 7015 Albert Einstein Drive
City: Columbia
State: MD
Zip: 21046
Country: US
Osiris Therapeutics is a Maryland-based biotechnology company that researches, develops and commercializes stem cell therapy for tissue regeneration.
Contact Phone:
+14435451800
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/4/2006
Ticker Symbol:
OSIR
IPO Price:
$11/share
Amount Raised:
$39M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2007 | Post-IPO Debt | 1 | $30M |
Friedli Corporate Finance Friedli Corporate Finance Friedli Corporate Finance Friedli Corporate Finance |
6/2007 | Private Placement | $20M | 12/2005 | Equity | $19M | 8/2006 | IPO | $38.5M | 7/2018 | Venture Round | 2 | - |
Arvind Gupta SOSV Arvind Gupta Arvind Gupta SOSV Arvind Gupta |
6/2005 | Private Equity Round | $50M | 4/2014 | Post-IPO Equity | $0 |
Mesoblast Mesoblast Mesoblast Mesoblast |
7/2018 | Venture Round | 2 | - |
Arvind Gupta SOSV Arvind Gupta Arvind Gupta SOSV Arvind Gupta |
4/2014 | Post-IPO Equity | 1 | $15M |
Mesoblast Mesoblast Mesoblast Mesoblast |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|